Results 121 to 130 of about 22,716 (169)

Structural and mechanistic basis of mTORC2 activation of protein kinase AKT/PKB. [PDF]

Biochem J
Chu N, Le N, Nebie O, Yang S.
europepmc   +1 more source

Zebrafish Models of Parkinson's Disease: From Pathogenesis to Drug Discovery. [PDF]

Int J Mol Sci
Park HC, Seo Y, Han YJ, Cho SH, Kim MJ.
europepmc   +1 more source

Parkinson disease (autosomal recessive, juvenile) 2 parkin (PARK2; Parkin); PTEN induced putative kinase 1 (PINK1); DJ-1 (PARK7); synuclein, α-interacting protein synphilin (SNCAIP) [PDF]

Science-Business eXchange, 2009
openaire   +1 more source

PI3K/AKT/mTOR axis in vascular malformations: from molecular insights to targeted clinical trials. [PDF]

Orphanet J Rare Dis
Zheng YY, Hua C, Lin XX.
europepmc   +1 more source

Mitochondria as convergence hubs for innate immunity pathways. [PDF]

Commun Biol
Guo Y, Xue Y.
europepmc   +1 more source

Assessment of Genetic Mutations in Genes Alpha-Synuclein (SNCA), Parkin (PRKN), Leucine-Rich Repeat Kinase2 (LRRK2 or Dardarin), PTEN-Induced Putative Kinase 1 (PINK1), DJ-1 and ATP13A2 Induced Parkinson's Disease (PD) in Patients Tabriz, IRAN

International Journal of Genomics and Data Mining, 2017
Shahin Asadi, Mahsa Jamali, Samaneh Sadeh Dell   +2 more
openaire   +1 more source

PINK1 overexpression suppresses p38 MAPK/NF‑κB signaling to attenuate chondrocyte senescence in osteoarthritis. [PDF]

Int J Mol Med
Jie L, Zhang Y, Liu J, Fu H, Zhu Z, Huang Z, Shi X, Wang P, Yin S.   +8 more
europepmc   +1 more source

MUC1 Protects Preimplantation Embryos In Vitro via Clearance of ROS by Triggering Mitophagy. [PDF]

Cells
Yang J, Li D, Yang C, Deng H, Lin K, Liao B, Liao X, Liu Y, Lyu Q, Huang L.   +9 more
europepmc   +1 more source

Role of mitophagy in acute and fractionated gamma radiation-induced nephropathy in rats: insight into molecular biology and repurposing of rosuvastatin. [PDF]

Naunyn Schmiedebergs Arch Pharmacol
Fadel NA, Lotfy DM, Gomaa AA, Bishr A.
europepmc   +1 more source

Metabolic Concepts of Sodium-Glucose Cotransporter 2 Inhibitors-Based Therapies Against Hepatocarcinogenesis and Therapy Resistance in Hepatocellular Carcinoma. [PDF]

Life (Basel)
Chung HH.
europepmc   +1 more source